查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948369

2026年全球結核病診斷市場報告

Tuberculosis Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，結核病診斷市場顯著擴張，預計將從2025年的23.4億美元成長到2026年的25.2億美元，複合年成長率為7.9%。過去幾年的成長可歸因於多種因素，例如全球結核病負擔加重、公共衛生篩檢計畫的擴展、塗片顯微鏡基礎設施的建設、國際社會對結核病控制的投入以及基於培養的診斷方法的採用。

預計未來幾年結核病診斷市場規模將強勁成長，2030年將達到33.7億美元，複合年成長率（CAGR）為7.5%。預測期內的成長可歸因於以下因素：對快速、準確的結核病診斷需求不斷成長、對抗藥性結核病檢測的日益重視、分散式診斷檢測的擴展、分子診斷投資的增加以及人工智慧輔助診斷工具的整合。預測期內的主要趨勢包括：分子結核病檢測的日益普及、快速診斷平台的廣泛應用、抗藥性檢測的日益整合、照護現場檢測的擴展以及對高靈敏度診斷的日益重視。

結核病（TB）發病率的不斷上升預計將持續推動對結核病診斷的需求。結核病是一種高度傳染性的細菌感染疾病，主要侵襲肺部，需要快速識別以防止嚴重的健康併發症和進一步傳播。結核病負擔日益加重主要是由於愛滋病毒/愛滋病疫情的蔓延，愛滋病毒/愛滋病會削弱免疫系統，並顯著增加罹患活動性結核病的風險。發病率的上升促使人們需要快速、準確的就地檢驗，並採用能夠儘早啟動治療和改善疾病管理的結核病診斷解決方案。例如，根據英國衛生安全局（負責英格蘭衛生安全的政府機構）於2025年10月發布的報告，2024年英格蘭的結核病病例數將同比成長13.6%，達到5490例（上一年為4831例）。因此，結核病發病率的上升正在推動結核病診斷市場的擴張。

結核病診斷領域的主要企業正優先考慮產品創新和先進診斷解決方案的開發，以鞏固其市場地位。結核病診斷測試包括各種醫學評估和實驗室方法，用於確定受檢者是否感染了結核分枝桿菌（即引起結核病的細菌）。這些測試對於識別活動性結核病、潛伏性感染和抗藥性菌株至關重要，從而能夠及時採取適當的檢查室治療性介入。例如，2023年2月，總部位於印度的技術主導診斷服務供應商Redcliffe Labs推出了BD MAX MDR TB Test，這是一種旨在作為第一線檢測方案的診斷解決方案，可幫助臨床醫生快速檢測結核病和多重抗藥性。此測試在BD MAX分子診斷系統上運行，可同時檢測結核病致病菌並識別與第一線藥物異煙肼（INH）和利福平（RIF）抗藥性相關的基因突變。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球結核病診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 擴大結核病分子檢測的應用
    • 快速診斷平台的使用日益增多
    • 藥物抗藥性檢測技術的整合正在取得進展
    • 擴大照護現場
    • 人們對高靈敏度診斷的興趣日益濃厚

第5章 終端用戶產業市場分析

  • 醫院和診斷檢查室
  • 參考檢查室
  • 公共衛生機構
  • 醫生辦公室檢查室
  • 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球結核病診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球結核病診斷市場規模、對比及成長率分析
  • 全球結核病診斷市場表現：規模與成長，2020-2025年
  • 全球結核病診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 按測試類型
  • 放射線檢查、核酸檢查、細胞激素檢測、抗藥性檢測、皮膚試驗/結核菌素試驗（TST）、血液/血清學檢查、塗片顯微鏡檢查、細胞培養試驗及其他類型的檢測
  • 按疾病階段
  • 潛伏性結核病，活動性結核病
  • 最終用戶
  • 醫院與診斷檢查室、診所檢查室、參考檢查室、學術研究機構
  • 按類型細分：放射攝影
  • 胸部X光片、 電腦斷層掃描
  • 按類型細分：核酸檢測
  • 聚合酵素鏈鎖反應（PCR）、核酸增幅檢查（NAAT）
  • 按類型細分：細胞激素檢測
  • 干擾素-γ釋放試驗（IGRA）
  • 按類型細分：抗藥性檢測
  • GeneXpert MTB/RIF 線性探針檢測
  • 按類型細分：皮膚測試/一對一測試 (TST)
  • 結核菌素皮膚試驗（TST）
  • 按類型細分：血液和血清檢測
  • 抗體血清學檢測
  • 按類型細分：塗片顯微鏡
  • 抗酸桿菌（AFB）塗片檢查
  • 按類型細分：基於細胞培養的檢測
  • 固體培養基培養、液體培養基培養
  • 按類型細分：其他測試類型
  • 分子檢測、先進影像診斷技術

第10章 區域與國家分析

  • 全球結核病診斷市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球結核病診斷市場：國家、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 結核病診斷市場：競爭格局與市場佔有率（2024 年）
  • 結核病診斷市場：公司估值矩陣
  • 結核病診斷市場：公司概況
    • Beckton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Qiagen NV
    • BioMerieux SA
    • Danaher Corporation

第37章：其他領先和創新企業

  • PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics sro, Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年結核病診斷市場：提供新機會的國家
  • 2030年結核病診斷市場：充滿新機會的細分市場
  • 2030年結核病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MTDIA02_G26Q1

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

Tariffs are impacting the tuberculosis diagnostics market by increasing costs of imported reagents, diagnostic kits, molecular testing instruments, imaging components, and laboratory consumables. Public health systems and diagnostic laboratories in low- and middle-income regions are most affected due to dependence on imported testing supplies, while developed markets face higher equipment costs. These tariffs are raising testing expenses and affecting screening coverage. However, they are also encouraging local manufacturing of diagnostic kits, regional reagent production, and technology transfer initiatives supporting long-term diagnostic capacity building.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to global tuberculosis disease burden, expansion of public health screening programs, availability of smear microscopy infrastructure, international funding for tb control, adoption of culture-based diagnostics.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for rapid and accurate tb diagnosis, rising focus on drug-resistant tb detection, expansion of decentralized diagnostic testing, increasing investments in molecular diagnostics, integration of ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of molecular tb testing methods, rising use of rapid diagnostic platforms, growing integration of drug resistance detection, expansion of point-of-care tb testing, enhanced focus on high-sensitivity diagnostics.

The increasing incidence of tuberculosis is expected to drive demand for tuberculosis diagnostics going forward. Tuberculosis (TB) is a highly contagious bacterial infection that primarily affects the lungs and requires prompt identification to prevent serious health complications and further transmission. The growing burden of tuberculosis is largely attributed to the rising prevalence of HIV/AIDS, which weakens the immune system and significantly increases susceptibility to developing active TB disease. This rising incidence is supporting the adoption of tuberculosis diagnostic solutions by increasing the need for rapid, accurate, and point-of-care testing that enables early initiation of treatment and improved disease management. For instance, in October 2025, according to the UK Health Security Agency, a government body responsible for health security in England, tuberculosis cases in England rose by 13.6 percent in 2024 compared to 2023, with 5,490 reported cases in 2024 versus 4,831 cases in the previous year. Therefore, the growing incidence of tuberculosis is contributing to the expansion of the tuberculosis diagnostics market.

Leading companies operating in the tuberculosis diagnostics space are prioritizing product innovation and the development of advanced diagnostic solutions to strengthen their market presence. Tuberculosis diagnostic tests include a range of medical assessments and laboratory methods used to determine whether an individual is infected with Mycobacterium tuberculosis, the bacterium responsible for TB. These tests are critical for identifying active tuberculosis, latent infections, and drug-resistant strains, allowing timely and appropriate treatment interventions. For example, in February 2023, Redcliffe Labs, an India-based technology-enabled diagnostics service provider, launched the BD MAX MDR TB test, a diagnostic solution designed to help clinicians rapidly detect tuberculosis and multidrug resistance as a first-line test. Conducted on the BD MAX molecular diagnostic system, the test enables simultaneous detection of TB-causing bacteria and identification of genetic mutations associated with resistance to two key first-line drugs, isoniazid (INH) and rifampicin (RIF).

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
  • Subsegments:
  • 1) By Radiographic Tests: Chest X-rays; CT Scans
  • 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
  • 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
  • 4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
  • 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
  • 6) By Blood Or Serology Test: Serological Tests for Antibodies
  • 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
  • 8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
  • 9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
  • Companies Mentioned: Beckton Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Rad Laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co. Ltd; Kindstar Global; Siemens AG; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Meridian Bioscience; Abbott Laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Akonni Biosystems Inc; Epistem Limited; Gen-Probe; Bio Certica; BixBio
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Tuberculosis Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Tuberculosis Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Tuberculosis Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Tuberculosis Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Molecular Tb Testing Methods
    • 4.2.2 Rising Use Of Rapid Diagnostic Platforms
    • 4.2.3 Growing Integration Of Drug Resistance Detection
    • 4.2.4 Expansion Of Point-Of-Care Tb Testing
    • 4.2.5 Enhanced Focus On High-Sensitivity Diagnostics

5. Tuberculosis Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals And Diagnostic Laboratories
  • 5.2 Reference Laboratories
  • 5.3 Public Health Institutions
  • 5.4 Physician'S Office Laboratories
  • 5.5 Research Institutes

6. Tuberculosis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tuberculosis Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Tuberculosis Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tuberculosis Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tuberculosis Diagnostics Market Segmentation

  • 9.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
  • 9.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Latent Tuberculosis, Active Tuberculosis
  • 9.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
  • 9.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chest X-rays, CT Scans
  • 9.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
  • 9.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Interferon Gamma Release Assays (IGRAs)
  • 9.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • GeneXpert MTB/RIF, Line Probe Assays
  • 9.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tuberculin Skin Test (TST)
  • 9.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serological Tests for Antibodies
  • 9.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Acid-Fast Bacilli (AFB) Smear Test
  • 9.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Media Cultures, Liquid Media Cultures
  • 9.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Tests, Advanced Imaging Techniques

10. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 10.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tuberculosis Diagnostics Market

  • 11.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tuberculosis Diagnostics Market

  • 12.1. China Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tuberculosis Diagnostics Market

  • 13.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tuberculosis Diagnostics Market

  • 14.1. Japan Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tuberculosis Diagnostics Market

  • 15.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tuberculosis Diagnostics Market

  • 16.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tuberculosis Diagnostics Market

  • 17.1. South Korea Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tuberculosis Diagnostics Market

  • 18.1. Taiwan Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tuberculosis Diagnostics Market

  • 19.1. South East Asia Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tuberculosis Diagnostics Market

  • 20.1. Western Europe Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tuberculosis Diagnostics Market

  • 21.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tuberculosis Diagnostics Market

  • 22.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tuberculosis Diagnostics Market

  • 23.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tuberculosis Diagnostics Market

  • 24.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tuberculosis Diagnostics Market

  • 25.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tuberculosis Diagnostics Market

  • 26.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tuberculosis Diagnostics Market

  • 27.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tuberculosis Diagnostics Market

  • 28.1. North America Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tuberculosis Diagnostics Market

  • 29.1. USA Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tuberculosis Diagnostics Market

  • 30.1. Canada Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tuberculosis Diagnostics Market

  • 31.1. South America Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tuberculosis Diagnostics Market

  • 32.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tuberculosis Diagnostics Market

  • 33.1. Middle East Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tuberculosis Diagnostics Market

  • 34.1. Africa Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tuberculosis Diagnostics Market Regulatory and Investment Landscape

36. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Tuberculosis Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Tuberculosis Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Tuberculosis Diagnostics Market Company Profiles
    • 36.3.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc

38. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

40. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Tuberculosis Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Tuberculosis Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Tuberculosis Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer